ARCHIVES

Early ADT Doesn’t Offer Survival Advantage—ASCO

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Klausner To Serve As Advisor On Bioterrorism For NAS.

January 4, 2002

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

New Research Grant Awards

October 18, 1974

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984